| LDR | | 01846nam u200433 4500 |
| 001 | | 000000418314 |
| 005 | | 20190215162748 |
| 008 | | 181129s2018 |||||||||||||||||c||eng d |
| 020 | |
▼a 9780355663044 |
| 035 | |
▼a (MiAaPQ)AAI10745010 |
| 035 | |
▼a (MiAaPQ)wustl:12421 |
| 040 | |
▼a MiAaPQ
▼c MiAaPQ
▼d 247004 |
| 082 | 0 |
▼a 616.99 |
| 100 | 1 |
▼a Meyer, Melissa A.
▼0 (orcid)0000-0003-3050-4819. |
| 245 | 10 |
▼a Tumors Interrupt IRF8-Mediated Dendritic Cell Development to Overcome Immune Surveillance. |
| 260 | |
▼a [S.l.]:
▼b Washington University in St. Louis.,
▼c 2018. |
| 260 | 1 |
▼a Ann Arbor:
▼b ProQuest Dissertations & Theses,
▼c 2018. |
| 300 | |
▼a 119 p. |
| 500 | |
▼a Source: Dissertation Abstracts International, Volume: 79-07(E), Section: B. |
| 500 | |
▼a Adviser: David G. DeNardo. |
| 502 | 1 |
▼a Thesis (Ph.D.)--Washington University in St. Louis, 2018. |
| 506 | |
▼a This item is not available from ProQuest Dissertations & Theses. |
| 520 | |
▼a Tumors employ multiple mechanisms to evade immune surveillance. One mechanism is tumor-induced myelopoiesis, which expands immune suppressive granulocytes and monocytes to create a protective tumor niche shielding even antigenic tumors. As myelo |
| 590 | |
▼a School code: 0252. |
| 650 | 4 |
▼a Oncology. |
| 650 | 4 |
▼a Cellular biology. |
| 650 | 4 |
▼a Immunology. |
| 690 | |
▼a 0992 |
| 690 | |
▼a 0379 |
| 690 | |
▼a 0982 |
| 710 | 20 |
▼a Washington University in St. Louis.
▼b Biology & Biomedical Sciences (Molecular Cell Biology). |
| 773 | 0 |
▼t Dissertation Abstracts International
▼g 79-07B(E). |
| 773 | |
▼t Dissertation Abstract International |
| 790 | |
▼a 0252 |
| 791 | |
▼a Ph.D. |
| 792 | |
▼a 2018 |
| 793 | |
▼a English |
| 856 | 40 |
▼u http://www.riss.kr/pdu/ddodLink.do?id=T14996844
▼n KERIS
▼z 이 자료의 원문은 한국교육학술정보원에서 제공합니다. |
| 980 | |
▼a 201812
▼f 2019 |
| 990 | |
▼a ***1012033 |